Starling Oncology, Inc. (DFPH) Revenue 2020–2025
Starling Oncology, Inc. (DFPH) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$502.7MFY2025 · since FY2020: $187.5M → $502.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $502.7M | +27.8% |
| FY2024 | $393.4M | +21.3% |
| FY2023 | $324.2M | +28.4% |
| FY2022 | $252.5M | +24.4% |
| FY2021 | $203.0M | +8.3% |
| FY2020 | $187.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice